The Effects of Carbohydrates in Irritable Bowel Syndrome
Key facts
- Who runs it
- Sahlgrenska University Hospital
- Where
- Sweden1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 65 people enrolled
- Started
- 30 Mar 2021
- Ended
- 2 Jun 2025
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Fructan reintroduction
- Placebo reintroduction
- Record updated
- 24 November 2025
Who can take part
- Age
- 18 years to 50 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- IBS according to ROME IV criteria (with diarrhoea)
Who cannot take part
- Usage of antibiotics within 4 weeks prior to inclusion
- Medications: laxatives, neuromodulators or opioids (morphine, codeine, tramadol…)
- Celiac disease or any other gastroenterology disease (such as inflammatory bowel disease, celiac disease, microscopic colitis, diverticulitis, radiation enteritis)
- Suspected or known strictures, fistulas or physiological/mechanical GI obstruction, history of gastric bezoar
- Heart-, liver-, neurological-, or current psychiatric disease, diabetes, obesity (BMI>30), other disease or surgery to the abdomen that affected intestinal function
- Swallowing disorders/dysphagia to food or pills
- Allergy or intolerances to foods
- Appendicectomy and cholecystectomy <3 months
- Implantable or portable electro-mechanical medical devices, e.g. pacemakers
- Compliance to a special diet (including vegan, vegetarian, gluten-free or low FODMAP diet)
- Pregnant or breast feeding
- Usage of alcohol more than 14 units per week
- No new pharmacological treatment during the study period
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Food and their components are often reported as gastrointestinal (GI) symptom triggers in patients with IBS. The current interest in dietary management in IBS, has largely focused on the negative effect of poorly absorbed and subsequently fermented carbohydrates (FODMAP - Fermentable Oligo-, Di-, Mono-saccharides And Polyols). These unabsorbed carbohydrates can generate GI symptoms through osmosis, with increased amount of fluid in the gut lumen, and via modification of gut microbiota composition and function (fermentation and production of gas).
Read full original descriptionShow less
Studies assessing diets low in FODMAPs have shown promising results in symptom improvement in some IBS patients, but not in all. The low FODMAP diet, as it is used today, is restrictive and difficult for patients to accommodate in their daily life. Moreover, the effect of this diet on microbiota composition and function is not defined, and there are also concerns that restrictive diets may lead to nutritional inadequacy.
Fructan is a specific FODMAP which is built of fructose polymers. Examples of foods that contain fructans are wheat, onion, garlic and banana. The daily dietary intake of fructans varies approximately between 3 and 6 grams. Fructans are potential triggers of GI symptoms in IBS however, they are currently also used as prebiotic supplements. A recent systematic review and meta-analysis concluded that low dosages of fructans do not worsen GI symptoms, but they do increase the beneficial bifidobacteria. It remains unclear whether the potential benefits of fructans outweigh the potential harmful effects in patients with IBS.
The investigators are aiming to assess the effects of fructans, as well as predictive factors and mechanisms involved, and to compare with placebo in IBS patients. The investigators will assess GI symptom severity, visceral sensitivity, intestinal gas production, gut immunity and microbiota, and metabolites produced in the gut.
The 2 groups in the trial
- Fructan powderTreatment being tested
2 g of fructan powder 3 times per day for 7 days
Treatment: Fructan reintroduction
- PlaceboPlacebo, for comparison
2g of placebo (maltodextrin) 3 times per day for 7 days.
Treatment: Placebo reintroduction
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effects of Fructans in Irritable Bowel Syndrome
- Record updated
- 24 November 2025